In the Matter of Norhan Mansour

New Jersey Superior Court Appellate Division·Decided May 1, 2026·No. A-3876-23/A-3886-23·Unpublished

Opinion

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION This opinion shall not "constitute precedent or be binding upon any court ." Although it is posted on the internet, this opinion is binding only on the parties in the case and its use in other cases is limited . R. 1:36-3.

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION

DOCKET NOS. A-3876-23

A-3886-23

IN THE MATTER OF NORHAN MANSOUR, JERSEY CITY POLICE DEPARTMENT.

IN THE MATTER OF OMAR POLANCO, JERSEY CITY POLICE DEPARTMENT.

Argued December 16, 2025 – Decided May 1, 2026

Before Judges Gooden Brown, Rose and Torregrossa-

O'Connor.

On appeal from the New Jersey Civil Service Commission, Docket Nos. 2024-484 and 2024-814.

Kyle J. Trent argued the cause for appellant Jersey City Police Department (Apruzzese, McDermott, Mastro & Murphy, PC, attorneys; Arthur R. Thibault Jr., of counsel and on the briefs; Kyle J. Trent and Timothy J.

Dunn, on the briefs).

Michael P. Rubas (Law Offices of Michael Peter Rubas, LLC) argued the cause for respondents Norhan Mansour and Omar Polanco.

Melina Layerenza, Assistant Attorney General, argued the cause for respondent Civil Service Commission (Matthew J. Platkin, Attorney General, attorney;

Michael L. Zuckerman, Deputy Solicitor General, of counsel; Liza B. Fleming and Mark A. Gulbranson, Jr., Deputy Attorneys General, on the brief).

PER CURIAM In these consolidated appeals, the Jersey City Police Department (JCPD)

challenges two July 24, 2024 Civil Service Commission (CSC) decisions denying reconsideration and a stay of the CSC's prior decisions directing the JCPD to reinstate police officers Norhan Mansour and Omar Polanco, both of whom were removed after testing positive for cannabinoids. In its decisions, the CSC held, by removing the officers for their off-duty use of regulated cannabis, the JCPD violated the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA), N.J.S.A. 24:6I-31 to -56. The JCPD argues the federal Gun Control Act (GCA), 18 U.S.C. §§ 921-934, preempts CREAMMA. Unpersuaded, we affirm. 1

1 We simultaneously issue our opinion in another matter affirming the CSC's decision rejecting the JCPD's federal law preemption argument: In re Patten, Jersey City Police Dep't, A-3126-23.

A-3876-23

I.

The undisputed facts in both matters are straightforward and their events proceeded along parallel paths. We summarize the pertinent factual and procedural posture.

In September 2022, the JCPD administered random drug tests to Mansour and Polanco. After both officers tested positive for the presence of cannabinoids (THC), they were separately interviewed by members of the Internal Affairs Unit. Both officers acknowledged they used cannabis at some point before their random drug tests, but stated they never used unregulated cannabis. Mansour produced receipts for three purchases made in June, July, and August 2022; Polanco acknowledged he did not retain the receipts from purchases made prior to his drug test.

The JCPD issued notices of immediate suspension and preliminary disciplinary action (PNDA), charging both officers with violating state law, state regulations, and departmental rules. In the PNDAs, the JCPD alleged the officers' cannabis use resulted in their inability "to perform an essential function of [their] position[s] as . . . police officer[s] – carry and possess a firearm and ammunition." The PNDAs did not assert the officers used cannabis on duty nor the cannabis they used was unregulated.

A-3876-23

Following separate departmental hearings, in March 2023, the JCPD issued amended final notices of disciplinary action, sustaining most of the charges and removing both officers from their positions. The matters were separately transmitted to the Office of Administrative Law as contested cases and heard on cross-motions for summary decision before different Administrative Law Judges (ALJ).

A. The Mansour Matter

In her decision, the ALJ summarized the facts that led to the charges against Mansour. The ALJ also recognized, "In April 2022, [the] JCPD Police Director and Deputy Chief issued an order stating that officers were prohibited from using cannabis on or off duty as it is illegal under federal law for cannabis users to possess, carry or use firearms." The ALJ further observed when Mansour was tested "[i]n September 2022[,] regulated marijuana, cannabis was legal in New Jersey and available for purchase from in[-]state cannabis dispensaries." She further noted the JCPD did not allege Mansour used cannabis or was impaired while on duty, or used unregulated cannabis.

Turning to her legal conclusions, the ALJ addressed the issues raised, including the JCPD's preemption argument, in view of the governing legal

A-3876-23

principles. The ALJ recognized in August 2021, prior to Mansour's random drug screening, "N.J.S.A. 24:6I-52 became operative" and states, in relevant part:

No employer shall refuse to hire or employ any person or shall discharge from employment or take any adverse action against any employee with respect to compensation, terms, conditions, or other privileges of employment because that person does or does not smoke, . . . or otherwise use cannabis items, and an employee shall not be subject to any adverse action by an employer solely due to the presence of cannabinoid metabolites in the employee's bodily fluid from engaging in conduct permitted under [CREAMMA].

[N.J.S.A. 24:6I-52(a)(1).]

The ALJ further observed CREAMMA "authorize[s] drug testing of employees by their employer when there is reasonable suspicion of the employee's use of cannabis while working or when there are observable signs of intoxication; and random drug testing is also permitted but only to determine use during prescribed work hours." Finding the JCPD was subject to CREAMMA, and the lack of any evidence in the record Mansour displayed any "signs of intoxication, suspected drug use, or impairment during work hours," the ALJ concluded Mansour's termination violated N.J.S.A. 24:6I-52(a)(1) and "the JCPD Rules that form[ed] the basis of Mansour's removal [we]re preempted by [CREAMMA]" because the Rules permitted "removal or discipline of a

A-3876-23

police officer simply for testing positive for the use of cannabinoids and nothing more."

In reaching her decision, the ALJ was not persuaded by the JCPD's contention that sections 922(d) and (g) of the GCA preempt CREAMMA under a "conflict preemption" theory. The ALJ elaborated:

The [JCPD] has failed to demonstrate that a "positive conflict" exists between [CREAMMA] and the [GCA]

because even if marijuana consumption remains unlawful under federal law, nothing in [CREAMMA]

requires anyone to violate federal law, and while [CREAMMA] provides immunity from State prosecution and from adverse employment actions, it does not purport to offer any immunity from any violation of federal law – the federal government is still free to prosecute cannabis users in New Jersey even though State prosecutors and law enforcement may not.

Although the JCPD did not include its exceptions to the ALJ's initial decision in its appellate appendix, we glean from the CSC's August 2, 2023 decision that the JCPD challenged the ALJ's conclusion that the GCA does not preempt CREAMMA. Following its de novo review of the record, the CSC adopted the ALJ's factual and legal conclusions, reversing Mansour's removal. Accordingly, the CSC reinstated Mansour "with mitigated back pay, benefits, and seniority" and "reasonable counsel fees" under the governing regulations. See N.J.A.C. 4A:2-2.10, -2.12.

A-3876-23

Free access — add to your briefcase to read the full text and ask questions with AI

In the Matter of Norhan Mansour, (N.J. Ct. App. 2026).

In the Matter of Norhan Mansour (In the Matter of Norhan Mansour) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Fort Halifax Packing Co. v. Coyne
482 U.S. 1 (Supreme Court, 1987)
Gade v. National Solid Wastes Management Assn.
505 U.S. 88 (Supreme Court, 1992)
Medtronic, Inc. v. Lohr
518 U.S. 470 (Supreme Court, 1996)
Altria Group, Inc. v. Good
555 U.S. 70 (Supreme Court, 2008)
Hyland v. Fukuda
580 F.2d 977 (Ninth Circuit, 1978)
In Re Virtua-West Jersey Hospital Voorhees for a Certificate of Need
945 A.2d 692 (Supreme Court of New Jersey, 2008)
In Re Arenas
897 A.2d 442 (New Jersey Superior Court App Division, 2006)
In Re Carroll
772 A.2d 45 (New Jersey Superior Court App Division, 2001)
In Re Carry Permit of Andros
958 A.2d 78 (New Jersey Superior Court App Division, 2008)
City of Gary Ex Rel. King v. Smith & Wesson Corp.
94 F. Supp. 2d 947 (N.D. Indiana, 2000)
In Re Reglan Litigation
142 A.3d 725 (Supreme Court of New Jersey, 2016)
Keyes v. Sessions
282 F. Supp. 3d 858 (M.D. Pennsylvania, 2017)
In re Stallworth
26 A.3d 1059 (Supreme Court of New Jersey, 2011)
Allstars Auto Grp., Inc. v. N.J. Motor Vehicle Comm'n
189 A.3d 333 (Supreme Court of New Jersey, 2018)